{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:19:30Z","timestamp":1776259170078,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-18736-1","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T19:05:08Z","timestamp":1763060708000},"page":"4656-4667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in Clinicopathologic and Treatment Outcomes in Patients with Gastric Adenocarcinoma in the United States Between 2004 and 2021"],"prefix":"10.1245","volume":"33","author":[{"given":"Ali","family":"Esparham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Agriantonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Shafaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"18736_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"18736_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"18736_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.surg.2019.04.036","volume":"166","author":"JR Bergquist","year":"2019","unstructured":"Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019;166(4):547\u201355.","journal-title":"Surgery."},{"issue":"3","key":"18736_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199\u2013211.","journal-title":"Ann Intern Med."},{"issue":"10","key":"18736_CR5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/j.1365-2036.2010.04471.x","volume":"32","author":"JH Rubenstein","year":"2010","unstructured":"Rubenstein JH, Taylor J. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2010;32(10):1222\u20137.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"18736_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2015.05.059","volume":"149","author":"P Tan","year":"2015","unstructured":"Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149(5):1153-62.e3.","journal-title":"Gastroenterology."},{"issue":"1","key":"18736_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/annonc\/mdr135","volume":"23","author":"I Tramacere","year":"2012","unstructured":"Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23(1):28\u201336.","journal-title":"Ann Oncol."},{"issue":"10","key":"18736_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol."},{"issue":"10","key":"18736_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037\u201348.","journal-title":"Cancer Commun (Lond)."},{"issue":"1","key":"18736_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol."},{"issue":"9","key":"18736_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11605-023-05735-4","volume":"27","author":"FB Maegawa","year":"2023","unstructured":"Maegawa FB, Patel AD, Serrot FJ, Patel SG, Stetler JL, Patel DC, et al. Gastric cancer surgery in the US: a contemporary trend analysis of lymphadenectomy and the impact of minimally invasive approaches. J Gastrointest Surg. 2023;27(9):1825\u201336.","journal-title":"J Gastrointest Surg."},{"issue":"3","key":"18736_CR12","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"18736_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","volume":"23","author":"JA Ajani","year":"2025","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Corvera CU, Das P, Enzinger PC, et al. Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025;23(5):169\u201391.","journal-title":"J Natl Compr Canc Netw."},{"issue":"8","key":"18736_CR14","first-page":"Cd004064","volume":"8","author":"AD Wagner","year":"2017","unstructured":"Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8(8):Cd004064.","journal-title":"Cochrane Database Syst Rev."},{"key":"18736_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.948647","volume":"13","author":"X Jin","year":"2022","unstructured":"Jin X, Liu Z, Yang D, Yin K, Chang X. Recent progress and future perspectives of immunotherapy in advanced gastric cancer. Front Immunol. 2022;13:948647.","journal-title":"Front Immunol."},{"key":"18736_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijsu.2020.07.053","volume":"82","author":"GP Guerrini","year":"2020","unstructured":"Guerrini GP, Esposito G, Magistri P, Serra V, Guidetti C, Olivieri T, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: The largest meta-analysis. Int J Surg. 2020;82:210\u201328.","journal-title":"Int J Surg."},{"issue":"1","key":"18736_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.34910","volume":"155","author":"N Horesh","year":"2024","unstructured":"Horesh N, Emile SH, Garoufalia Z, Gefen R, Zhou P, Wexner SD. Trends in management and outcomes of colon cancer in the United States over 15 years: analysis of the National Cancer Database. Int J Cancer. 2024;155(1):139\u201348.","journal-title":"Int J Cancer."},{"key":"18736_CR18","unstructured":"Affordable Care Act (ACA). https:\/\/www.healthcare.gov\/glossary\/affordable-care-act\/. Accessed Jul 2, 2025."},{"issue":"4","key":"18736_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s10620-022-07659-6","volume":"68","author":"E Niroomand","year":"2023","unstructured":"Niroomand E, Kumar SR, Goldberg D, Kumar S. Impact of medicaid expansion on incidence and mortality from gastric and esophageal cancer. Dig Dis Sci. 2023;68(4):1178\u201386.","journal-title":"Dig Dis Sci."},{"issue":"1 Pt B","key":"18736_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.amjsurg.2022.02.002","volume":"224","author":"C Zhu","year":"2022","unstructured":"Zhu C, Sandilos G, Henry O, Sensenig R, Gaughan J, Spitz F, et al. Medicaid expansion is associated with earlier diagnosis of gastric cancer. Am J Surg. 2022;224(1 Pt B):539\u201345.","journal-title":"Am J Surg."},{"issue":"3","key":"18736_CR21","first-page":"147","volume":"6","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Gong YB, Xu HM. Neoadjuvant therapy strategies for advanced gastric cancer: current innovations and future challenges. Chronic Dis Transl Med. 2020;6(3):147\u201357.","journal-title":"Chronic Dis Transl Med."},{"issue":"3","key":"18736_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.1031","volume":"4","author":"CT Aquina","year":"2021","unstructured":"Aquina CT, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. National trends in the use of neoadjuvant therapy before cancer surgery in the US from 2004 to 2016. JAMA Netw Open. 2021;4(3):e211031.","journal-title":"JAMA Netw Open."},{"issue":"10184","key":"18736_CR23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet."},{"issue":"1","key":"18736_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med."},{"issue":"18","key":"18736_CR25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med."},{"issue":"9813","key":"18736_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet."},{"issue":"10294","key":"18736_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340.","journal-title":"Lancet."},{"key":"18736_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844803","volume":"12","author":"J Jiang","year":"2022","unstructured":"Jiang J, Ye G, Wang J, Xu X, Zhang K, Wang S. The comparison of short- and long-term outcomes for laparoscopic versus open gastrectomy for patients with advanced gastric cancer: a meta-analysis of randomized controlled trials. Front Oncol. 2022;12:844803.","journal-title":"Front Oncol."},{"key":"18736_CR29","doi-asserted-by":"crossref","unstructured":"Manara M, Aiolfi A, Sozzi A, Cal\u00ec M, Grasso F, Rausa E, et al. Short-term outcomes analysis comparing open, laparoscopic, laparoscopic-assisted, and robotic distal gastrectomy for locally advanced gastric cancer: a randomized trials network analysis. Cancers (Basel). 2024;16(9).","DOI":"10.3390\/cancers16091620"},{"key":"18736_CR30","unstructured":"NCCN. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines. In. National Comprehensive Cancer Network. Access date Jul 3, 2025."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18736-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:25:39Z","timestamp":1776255939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18736-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["18736"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18736-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is no conflict of interest to be declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}